Cost-Related Prescription Drug Rationing by Adults With Obesity

Alissa S Chen; Caroline G Borden; Maureen E Canavan; Joseph S Ross; Carol R Oladele; Kasia J Lipska

doi:10.1001/jamanetworkopen.2024.33000

Cost-Related Prescription Drug Rationing by Adults With Obesity

JAMA Netw Open. 2024 Nov 4;7(11):e2433000. doi: 10.1001/jamanetworkopen.2024.33000.

Authors

Alissa S Chen¹, Caroline G Borden², Maureen E Canavan³, Joseph S Ross^{1

4

5

6}, Carol R Oladele⁷, Kasia J Lipska^{6

8}

Affiliations

¹ National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
² Yale School of Medicine, New Haven, Connecticut.
³ Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut.
⁴ Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
⁵ Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.
⁶ Center for Outcomes Research and Evaluation, Yale New Haven Health System, New Haven, Connecticut.
⁷ Equity Research and Innovation Center, Yale School of Medicine, New Haven, Connecticut.
⁸ Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.

No abstract available

Plain language summary

This cross-sectional study analyzes data from the National Health Interview Survey to examine the prevalence of cost-related prescription drug rationing by adults with obesity.

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States